• Japanese
  • Korean
  • Chinese
Cover Image

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Abstract

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, the UK, Germany, France, Italy, Spain and Japan.
  • Key segments covered include vertebral augmentation and vertebroplasty devices.
  • Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within vertebral augmentation and vertebroplasty devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Stryker and CareFusion

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the vertebral augmentation and vertebroplasty devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the vertebral augmentation and vertebroplasty devices market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global vertebral augmentation and vertebroplasty devices market and the factors shaping it.

TOC

1 Table of Contents

1 Table of Contents 3

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 GlobalData Report Guidance 8

3 Vertebral Compression Fractures - Overview 9

  • 3.1 Epidemiology 9
  • 3.2 Acute and Chronic Symptoms 10
  • 3.3 Treatment Options for VCF 11
    • 3.3.1 Benefits of Vertebral Augmentation over Vertebroplasty 13
    • 3.3.2 Potential Complications 13
  • 3.4 Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices 13

4 Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization 15

  • 4.1 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 2004-2011 15
  • 4.2 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 2011-2018 16
  • 4.3 Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends 18
    • 4.3.1 Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies 18
    • 4.3.2 Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers 22
    • 4.3.3 Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth 23
  • 4.4 Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
    • 4.4.1 Market Drivers 30
    • 4.4.2 Market Restraints 38

5 Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 - 2018 42

  • 5.1 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 2004-2011 42
  • 5.2 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 2011-2018 43
  • 5.3 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 2004-2011 45
  • 5.4 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 2011-2018 46
  • 5.5 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 2004-2011 47
  • 5.6 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 2011-2018 48
  • 5.7 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 2004-2011 49
  • 5.8 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 2011-2018 51
  • 5.9 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 2004-2011 52
  • 5.10 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 2011-2018 53
  • 5.11 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 2004-2011 54
  • 5.12 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 2011-2018 55
  • 5.13 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 2004-2011 56
  • 5.14 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 2011-2018 57

6 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment 59

  • 6.1 Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants 60
    • 6.1.1 Medtronic Inc. 60
    • 6.1.2 Stryker Corporation 65
    • 6.1.3 CareFusion 67

7 Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70

  • 7.1 Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes) 70
    • 7.1.1 Product Description 70
  • 7.2 Shield Kyphoplasty System, Soteira 71
    • 7.2.1 Product Description 71
  • 7.3 Kyphoplasty System, BONESUPPORT 71
    • 7.3.1 Product Description 71
  • 7.4 Acu-Cut Vertebral Augmentation System, Ascendx Spine 71
    • 7.4.1 Product Description 71
  • 7.5 V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes) 72
    • 7.5.1 Product Description 72
  • 7.6 Integrated System for Vertebroplasty, Skeltex 72
    • 7.6.1 Product Description 72
  • 7.7 OsseoFix Spinal Fracture Reduction System, Alphatec Spine 72
    • 7.7.1 Product Description 72

8 Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73

  • 8.1 Crosstrees Pod, Crosstrees Medical Inc. 73
    • 8.1.1 Product Description 73
    • 8.1.2 Product Status 73
  • 8.2 Kiva VCF System, Benvenue Medical, Inc. 74
    • 8.2.1 Product Description 74
    • 8.2.2 Product Status 74
  • 8.3 OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc. 74
    • 8.3.1 Product Description 74
    • 8.3.2 Product Status 74
  • 8.4 VerteLift Implant, SpineAlign Medical, Inc. 74
    • 8.4.1 Product Description 74
    • 8.4.2 Product Status 74
  • 8.5 AVAMAX Vertebroplasty Kits, CareFusion 75
    • 8.5.1 Product Description 75
    • 8.5.2 Product Status 75

9 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis 76

  • 9.1 List of Venture Financing Deals 77
  • 9.2 List of Debt Offerings 79
  • 9.3 List of Partnership Deals 80
  • 9.4 List of Equity Offerings Deals 80
  • 9.5 Key Deals 80
    • 9.5.1 Ascendx Spine Entered into Co-Marketing Agreement with Anwerina 80
    • 9.5.2 Benvenue Medical Raised $25m Series D Financing 81
    • 9.5.3 Shanghai Kinetic Medical Completed IPO for $60m 81

10 Appendix 82

  • 10.1 Market Definitions 82
    • 10.1.1 Vertebral Augmentation and Vertebroplasty Devices 82
  • 10.2 Acronyms 82
  • 10.3 Sources 83
  • 10.4 Research Methodology 87
    • 10.4.1 Secondary Research 88
    • 10.4.2 Primary Research 88
    • 10.4.3 Models 88
    • 10.4.4 Forecasts 89
    • 10.4.5 Expert Panels 89
  • 10.5 GlobalData Consulting 89
  • 10.6 Contact Us 89
  • 10.7 Disclaimer 89

List of Tables

1.1 List of Tables

  • Table 1: VCF Prevalence in Cancer Patients 10
  • Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004-2011 15
  • Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011-2018 17
  • Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009 18
  • Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008-2010 19
  • Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008-2011 21
  • Table 7: FREE (Fracture Reduction Evaluation), 2009 23
  • Table 8: FREE (Fracture Reduction Evaluation), 2011 24
  • Table 9: Cancer Patient Fracture Evaluation or CAFE, 2011 24
  • Table 10: Mortality Risk for Operated and Non-operated Vertebral Fracture Patients in the Medicare population or The SAVE study, 2011 25
  • Table 11: Three-year Outcomes after Kyphoplasty in Patients with Osteoporosis with Painful Vertebral Fractures , 2010 25
  • Table 12: Comparison of 5,766 Vertebral Compression Fractures Treated With or Without Kyphoplasty, 2010 26
  • Table 13: The Kiva System as a Vertebral Augmentation Treatment (KAST), Ongoing 27
  • Table 14: Balloon Kyphoplasty Versus Vertebroplasty for Treatment of Osteoporotic Vertebral Compression Fracture: a Prospective, Comparative and Randomized Clinical Study 27
  • Table 15: Adjacent Vertebral Fractures after Percutaneous Vertebral Augmentation of Osteoporotic Vertebral Compression Fracture: A Comparison of Balloon Kyphoplasty and Vertebroplasty, 2010 28
  • Table 16: Efficacy of Unipedicular Balloon Kyphoplasty for Treatment of Multiple Myeloma Vertebral Lesions, 2011 28
  • Table 17: Snapshot of New Diagnostic Technologies for Osteoporosis, 2010-2012 31
  • Table 18: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018 35
  • Table 19: Procedure Cost Comparison, Vertebroplasty vs. Vertebral Augmentation, the US, 2007-2008 36
  • Table 20: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 40
  • Table 21: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004-2011 42
  • Table 22: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011-2018 44
  • Table 23: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004-2011 45
  • Table 24: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011-2018 46
  • Table 25: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004-2011 47
  • Table 26: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011-2018 48
  • Table 27: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004-2011 50
  • Table 28: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011-2018 51
  • Table 29: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004-2011 52
  • Table 30: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011-2018 53
  • Table 31: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($), 2004-2011 54
  • Table 32: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011-2018 55
  • Table 33: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004-2011 56
  • Table 34: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011-2018 58
  • Table 35: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59
  • Table 36: Medtronic, Key Marketed Products, 2012 60
  • Table 37: Kyphoplasty Settlements Between Hospitals and US Federal Government, 2009 ─ 2011 62
  • Table 38: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63
  • Table 39: Stryker, Key Marketed Products, 2012 65
  • Table 40: CareFusion, Key Marketed Products, 2012 68
  • Table 41: Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70
  • Table 42: Confidence Spinal Cement System, Description, 2011 70
  • Table 43: Shield Kyphoplasty System, Description, 2011 71
  • Table 44: Kyphoplasty System, Description, 2011 71
  • Table 45: Acu-Cut Vertebral Augmentation System, Description, 2011 71
  • Table 46: V-MAX Delivery System, Description, 2011 72
  • Table 47: Integrated System for Vertebroplasty (ISV), Description, 2011 72
  • Table 48: OsseoFix Spinal Fracture Reduction System, Description, 2010 72
  • Table 49: Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73
  • Table 50: Crosstrees Pod, Status 73
  • Table 51: Kiva VCF System, Status 74
  • Table 52: OsseoFix Spinal Fracture Reduction System, Status 74
  • Table 53: VerteLift Implant 74
  • Table 54: AVAMAX Vertebroplasty Kits, Status 75
  • Table 55: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010-2012 76
  • Table 56: Vertebral Augmentation and Vertebroplasty Devices Market, Venture Financing Deals, 2010-2012 77
  • Table 57: Vertebral Augmentation and Vertebroplasty Devices Market, Debt Offerings, 2010-2012 79
  • Table 58: Vertebral Augmentation and Vertebroplasty Devices Market, Partnership Deals, 2010-2012 80
  • Table 59: Vertebral Augmentation and Vertebroplasty Devices Market, Equity Offering Deals, 2012 80

List of Figures

1.2 List of Figures

  • Figure 1: Vertebral Compression Fracture, Treatment Options 11
  • Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010 13
  • Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004-2011 15
  • Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011-2018 16
  • Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008-2010 19
  • Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008-2011 21
  • Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
  • Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018 35
  • Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 39
  • Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004-2011 42
  • Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011-2018 43
  • Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004-2011 45
  • Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011-2018 46
  • Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004-2011 47
  • Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011-2018 48
  • Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004-2011 49
  • Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011-2018 51
  • Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004-2011 52
  • Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011-2018 53
  • Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2004-2011 54
  • Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011-2018 55
  • Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004-2011 56
  • Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011-2018 57
  • Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59

Figure 25: Medtronic, SWOT Analysis 61

  • Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63

Figure 27: Stryker, SWOT Analysis 65

Figure 28: CareFusion, SWOT Analysis 68

  • Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010-2012 76
Show More
Pricing